Healthcare | August 08, 2021
Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Board approves fundraise of Rs 1500 crore
Board approves fundraise of Rs 1500 crore
PAT rises to Rs 195.76 crore
The company expects revenue growth of 10-15 per cent in the US
Forex gains stood at Rs 20 crore for the quarter
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
India business is growing as per projections; whereas US business will bounce back soon.
Turnover of API division of ISLL stood at Rs 856.58 crore
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Subscribe To Our Newsletter & Stay Updated
